Overview

Study to Evaluate the Efficacy and Safety of Telmisartan/Amlodipine/Rosuvastatin

Status:
Completed
Trial end date:
2017-12-04
Target enrollment:
Participant gender:
Summary
To evaluate efficacy and safety of co-administrated temisartan/amlodipine and rosuvastatin in subjects with dyslipidemia with hypertension.
Phase:
Phase 3
Details
Lead Sponsor:
Jeil Pharmaceutical Co., Ltd.
Treatments:
Amlodipine
Rosuvastatin Calcium
Telmisartan